Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A known ✓ | P28223 | 2/20 | 0.33 |
| ▸ | HTR6 known ✓ | P50406 | 1/20 | 0.33 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 4/20 | 0.31 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.31 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.31 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.31 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.31 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.31 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 known ✓ | P35462 | 1/20 | 0.31 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.31 |
| ▸ | HTR2B known ✓ | P41595 | 1/20 | 0.31 |
| ▸ | CACNA1B known ✓ | Q00975 | 1/20 | 0.31 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.31 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.31 |
| ▸ | RET known ✓ | P07949 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6064765 | 1.00 | BRD4 (0.34) | BRD4CCL2HTR2AKDM4EHTR6 | |
| SCHEMBL29929995 | 0.98 | BRD4 (0.35) | BRD4CCL2HTR2AKDM4EHTR6 | |
| SCHEMBL1922929 | 0.98 | BRD4 (0.35) | BRD4CCL2HTR2AKDM4EHTR6 | |
| SCHEMBL8071475 | 0.96 | BRD4 (0.34) | BRD4CCL2HTR2AKDM4EHTR6 | |
| Chloromethane SCHEMBL7608709 | 0.95 | BRD4 (0.33) | BRD4CCL2HTR2AKDM4EHTR6 | |
| Phenol SCHEMBL23273222 | 0.90 | CA12 (0.35) | BRD4CCL2HTR2AHTR6SIGMAR1 | |
| Hydrochloric Acid SCHEMBL8380981 | 0.87 | POLB (0.33) | KDM4EMEN1PMP22KMT2ASMN1; SMN2 | |
| SCHEMBL8596413 | 0.85 | POLB (0.33) | HTR2AKDM4ELMNATP53CHRM2 | |
| Trifluoromethanesulfonic Acid SCHEMBL7681346 | 0.83 | BRD4 (0.31) | BRD4CCL2 | |
| SCHEMBL5174476 | 0.78 | ALDH1A1 (0.36) | KDM4EMEN1KMT2ASMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398167-B2 | Process for producing metallocenes | LANXESS ORGANOMETALLICS GMBH (DE) | 2025-08-26 | — | — | US | disclosed |
| EP-3917938-A1 | PROCESS FOR PRODUCING METALLOCENES | LANXESS Organometallics GmbH (DE) | 2021-12-08 | — | — | EP | disclosed |
| WO-2020156998-A1 | PROCESS FOR PRODUCING METALLOCENES | LANXESS ORGANOMETALLICS GMBH (DE) | 2020-08-06 | — | — | WO | disclosed |
| EP-3686209-A1 | PROCESS FOR PRODUCING METALLOCENES | LANXESS Organometallics GmbH (DE) | 2020-07-29 | — | — | EP | disclosed |
| EP-2559714-B1 | METHOD FOR PREPARING OLEFIN-DIENE COPOLYMER USING TRANSITION METAL COMPOUND INCLUDING THIOPHENE-CONDENSED RING CYCLOPENTADIENYL LIGAND | LOTTE CHEMICAL CORP (KR) | 2016-08-10 | — | — | EP | disclosed |
| EP-2559710-B1 | CATALYST COMPOSITION FOR POLYMERIZING OLEFIN AND METHOD FOR PREPARING POLYOLEFIN USING SAME | LOTTE CHEMICAL CORP (KR) | 2016-07-13 | — | — | EP | disclosed |
| US-6395846-B1 | COORDINATION CATALYST COMPRISING CLAY, ORGANOSILANE COMPOUND, WATER, AND TRANSITION METAL COMPLEX; QUALITY | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2002-05-28 | — | — | US | disclosed |
| EP-1026176-A1 | CATALYST FOR OLEFIN POLYMER PRODUCTION, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING OLEFIN POLYMER | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2000-08-09 | — | — | EP | disclosed |
| US-6063880-A | VIA SOLUTION, SUSPENSION, OR GAS PHASE HOMO- OR CO-POLYMERIZATION OF OLEFINS OF GIVEN FORMULA IN THE PRESENCE OF A CATALYST CONSISTING OF A METALLOCENE AND ALUMOXANE OF GIVEN FORMULAS; SIMPLIFICATION: NO HYDROGEN GAS NEEDED | TARGOR GMBH (DE) | 2000-05-16 | — | — | US | disclosed |
| US-5962719-A | Process for the preparation of a polyolefin wax | TARGOR GMBH (DE) | 1999-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398167-B2 | Process for producing metallocenes | CYP4F2, PRDX2, PRXL2A | HTR2A 3539/4885HTR6 4463/4885SIGMAR1 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.